Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

nebicapone

Known as: 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenylethanone 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Objectives  Patients with Parkinson's disease can benefit from controlled released levodopa dosage forms since there is a clear… Expand
2010
2010
To determine the efficacy, safety and tolerability of nebicapone, a new catechol‐O‐methyltransferase inhibitor for the treatment… Expand
Review
2010
Review
2010
  • K. Haasio
  • International review of neurobiology
  • 2010
  • Corpus ID: 21860089
The development of catechol-O-methyltransferase (COMT) inhibitors for the adjunct treatment to levodopa and aromatic L-amino acid… Expand
  • table I
  • figure 1
  • table II
  • figure 2
  • table III
Review
2010
Review
2010
  • S. Kaakkola
  • International review of neurobiology
  • 2010
  • Corpus ID: 883048
Entacapone and tolcapone are reversible COMT inhibitors which have been approved for clinical use in patients with Parkinson… Expand
2010
2010
Abstract Objective: To investigate the chronopharmacology of nebicapone, a new catechol-O-methyltransferase (COMT) inhibitor… Expand
2009
2009
The present study was designed to characterize pharmacodynamic and pharmacokinetic properties of nebicapone in rats and mice… Expand
2009
2009
BACKGROUND Nebicapone is a reversible catechol-O-methyltransferase (COMT) inhibitor. Coadministration of a COMT inhibitor with… Expand
  • figure 1
  • figure 2
  • table II
  • figure 3
  • table III
2008
2008
Objective: To investigate the effects of nebicapone, a new catechol-O-methyltransferase (COMT) inhibitor, on levodopa… Expand
2006
2006
Nebicapone (BIA 3-202; 1-[3,4-dihydroxy-5-nitrophenyl]-2-phenylethanone), a novel catechol-O-methyltransferase inhibitor, is… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
2002
2002
BIA 3-202, 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenylethanone 3, is a novel, reversible, and tight-binding peripheral inhibitor of… Expand